Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advi...( San Antonio Researcher Educator Brin...),Health

San Antonio Researcher, Educator Brings Expertise to Organization's Focus

on Breast Cancer Disparities

DALLAS, Oct. 2 /PRNewswire/ -- Susan G. Komen for the Cure, the global leader in the breast cancer movement, has appointed Amelie G. Ramirez, DrPH, of San Antonio, to its Scientific Advisory Board.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO )

Ramirez joins a group of five other leading breast cancer researchers and clinicians who comprise Komen's Scientific Advisory Board. The group's leader is Dr. Eric P. Winer, internationally known medical oncologist, researcher and educator from the Dana-Farber Cancer Institute and Harvard Medical Center, who is Komen's chief scientific advisor. Komen's Scientific Advisory Board lends insight and guidance to Komen in its grantmaking and health education initiatives. Komen's Scientific Advisory Board members also provide expert perspective and commentary on breaking news and emerging developments in breast cancer research and treatment.

Ramirez, who also serves as chairman of Komen's National Hispanic/Latino Advisory Council, is a professor of epidemiology and biostatistics at the University of Texas Health Science Center at San Antonio (UTHSCSA), where she also is founding director of the Institute for Health Promotion Research. In 2006, Dr. Ramirez received two endowments to support her research and that of the Institute. At UTHSCSA, she was named the Dielmann Chair in Health Disparities Research and Community Outreach. At the Cancer Therapy and Research Center (CTRC) in San Antonio, Dr. Ramirez was given the Max and Minnie Tomerlin Voelcker Endowed Chair in Cancer Healthcare Disparities and Outreach. Dr. Ramirez is director of outreach and health disparities at the CTRC.

Over the past 25 years, she has directed numerous state-, federal- and privately funded resear
'/>"/>